Brian Akerley
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$1.2MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 10, 2023 | NIH | STTR Phase I Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury | $286K | Advac Therapeutic LLC |
| Sep 8, 2022 | NIH | STTR Phase I Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury | $297K | Advac Therapeutic LLC |
| Sep 8, 2022 | NIH | STTR Phase I Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury | $583K | Advac Therapeutic LLC with UNIVERSITY OF MISSISSIPPI MED CTR |
Peer ranks
Federal funding#1,617
Awards as PI#822
Patents#273
Companies
- Advac Therapeutic LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.